Deck Kelly 4
4 · Inhibrx, Inc. · Filed Jan 3, 2023
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Deck Kelly
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-03+30,000→ 30,000 totalExercise: $23.30Exp: 2033-01-03→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.